focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 538.50
Bid: 534.00
Ask: 535.50
Change: 10.00 (1.89%)
Spread: 1.50 (0.281%)
Open: 516.00
High: 538.50
Low: 516.00
Prev. Close: 528.50
BAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (DD) - Babcock International

9 Jul 2010 10:42

RNS Number : 1153P
Bank of America Merrill Lynch
09 July 2010
 



FORM 8 (DD)

PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN

CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY

INVESTMENT CLIENTS)

Rules 8.1, 8.2 and 8.4 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Identity of the party to the offer or person Bank of America Merrill Lynch

acting

in concert making the disclosure:

(b) Owner or controller of interests and short

positions disclosed, if differenct from 1(a):

(c) Name of offeror/offeree in relation to whose Babcock International

relevant securities this form relates:

(d) Status of person making the disclosure: Advisor to VT Group Plc

(e) Date dealing undertaken: 08/07/2010

(f) Has the party previously disclosed, or is it today YES - .

disclosing, under the Code in respect of any

other party to this offer?

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a) Interests and short positions in the relevant securities of the offeror or offereee

to which the disclosure relates following the dealing

Class of relevant security:

GB0009697037 Interests Short Positions

Number % Number %

(1) Relevant securities owned 1,247,750 0.54% 0 0.00

and/or controlled:

(2) Derivatives (other than 0 0.00 0 0.00

options):

(3) Options and agreements 0 0.00 0 0.00

to purchase/sell:

TOTAL: 1,247,750 0.54%  0 0.00

(a) Rights subscribe for new securities (including directors' and other executive options)

Class of relevant security in relation to

which subscription right exists:

Details, including nature of the rights

concerned and relevant percenatges:

3. DEALINGS BY THE PERSON MAKING THE DISCLOSURE

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit

security securities

Common - GB0009697037 Purchase 871 GBP 6.2

Class of relevant Purchase/sale Number of Price per unit

security securities

Common - GB0009697037 Sale 30,000 GBP 6.17

Common - GB0009697037 Sale 70,000 GBP 6.19

(b) Derivatives transactions (other than options)

Class of Product description Nature of dealing Number of  Price per unit

relevant reference securities

security

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of Product Writing, Number of Exercise Type Expiry Option

relevant description purchasing, securities price date money

security selling, to which per unit paid/

varying etc. option received

relates per unit

(ii) Exercising

Class of relevant Product description Number of securities Exercise price per

security unit

(d) Other dealings (including subscribing for new securities)

Class of relevant Nature of dealing Details Price per unit (if

security applicable)

(a) Indemnity and other dealing

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the party to the offer or person acting in concert

making the disclosure and any other person:

NONE

(b) Agreements, arrangements or understandings relating to options or

Details of any agreement, arrangement or understanding, formal or informal, between

the party to the offer or person acting in concert making the disclosure and any other

person relating to:

(i) the voting rights of any relevant securities under any option; or

 NONE

(c) Attachments

Are any supplemental forms attached?

Supplemental Form 8 (Open Positions) (ii) the voting rights or future acquisition or disposal of any relevant securities to which NO

Supplemental Form 8 (SBL) any derivative is referenced NO

Date of disclosure 09/07/2010

Contact name Doug Berwick

Telephone number +44 20 7995 8859

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DCCSSFSUUFSSELW
Date   Source Headline
26th Apr 20241:15 pmRNSHolding(s) in Company
1st Mar 20247:00 amRNSContract awarded to refit UK nuclear submarine
21st Feb 20245:58 pmRNSDirector/PDMR Shareholding
15th Feb 20247:05 amRNSDirector announcement
14th Feb 20245:36 pmRNSDirector/PDMR Shareholding
14th Feb 20249:00 amRNSDirector appointment
9th Feb 20244:26 pmRNSDirector/PDMR Shareholding
7th Feb 20247:00 amRNSCapital Markets Day
6th Feb 20244:58 pmRNSDirector/PDMR Shareholding
5th Feb 202411:29 amRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSAmended Capital Markets Day start time
12th Jan 20247:00 amRNSNotice of Capital Markets Day
15th Dec 20234:51 pmRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNSResults for the six months ended 30 September 2023
10th Nov 202312:00 pmRNSBabcock signs £750 million infrastructure contract
7th Nov 20233:24 pmRNSHolding(s) in Company
30th Oct 20231:55 pmRNSHolding(s) in Company
28th Sep 20236:12 pmRNSResult of AGM
28th Sep 20237:00 amRNSAGM trading update
26th Sep 20235:57 pmRNSHolding(s) in Company
26th Sep 20235:56 pmRNSHolding(s) in Company
22nd Aug 20238:54 amRNSDirector/PDMR Shareholding
17th Aug 20232:52 pmRNSNotice of AGM
16th Aug 20235:16 pmRNSDirector/PDMR Shareholding
9th Aug 202310:00 amRNSDirector/PDMR Shareholding
4th Aug 20233:24 pmRNSDirector/PDMR Shareholding
3rd Aug 20233:34 pmRNSDirector/PDMR Shareholding
3rd Aug 202310:19 amRNSDirector/PDMR Shareholding
2nd Aug 20233:25 pmRNSDirector/PDMR Shareholding
2nd Aug 202310:22 amRNSDirector/PDMR Shareholding
31st Jul 20239:22 amRNSAnnual Financial Report
20th Jul 20237:16 amRNSFull year results for the year ended 31 March 2023
11th Jul 20237:00 amRNSDate of publication of FY23 preliminary statement
24th May 20238:54 amRNSDirectorate Change
20th Apr 20237:00 amRNSFY23 post close update and Type 31 contract update
1st Mar 20237:00 amRNSDisposal programme successfully concluded
15th Feb 20239:09 amRNSBabcock awarded contract to operate Skynet
2nd Feb 20238:13 amRNSDirectorate Change
20th Dec 202212:54 pmRNSStandard & Poor credit rating upgrade
9th Dec 20229:29 amRNSHolding(s) in Company
8th Dec 20229:06 amRNSHolding(s) in Company
22nd Nov 20227:00 amRNSHalf-year Report
9th Nov 20224:48 pmRNSHolding(s) in Company
3rd Nov 202212:13 pmRNSRestatement of pass-through revenue for HY22
3rd Nov 202211:08 amRNSRestatement of H1 2022 Results
21st Oct 20228:05 amRNSContract Win
18th Oct 20229:00 amRNSDirector appointment
13th Oct 202210:41 amRNSHolding(s) in Company
26th Sep 20224:00 pmRNSResult of AGM
26th Sep 20227:00 amRNSAGM Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.